Volume ,Issue
Research Progress on Traditional Chinese Medicine and Extracts for Treating Laryngeal Cancer
Laryngeal cancer is one of the common malignant tumors of the respiratory tract, most of which occur in the hypopharynx, among which the piriform fossa is the most common. Patients with subglottic laryngeal cancer lose the best treatment time because there are no obvious symptoms, while surgery is still the main treatment for early-stage tumors, and chemotherapy and immunotherapy are adjuvant in the middle and advanced stages. Among them, polysaccharides of traditional Chinese medicine have a significant effect on inhibiting tumors, which has the characteristics of multi-perspective and multi-mechanism synergistic effect, which can avoid drug resistance, and is a new field of natural medicine with great research value and development potential. Traditional Chinese medicine and its extracts mainly treat laryngeal cancer by inhibiting cell cycle and apoptosis, intervening in the metabolism of laryngeal cancer cells, affecting the microenvironment and metastasis of laryngeal cancer cells, and inhibiting the angiogenesis and metastasis of laryngeal cancer cells. This article provides a brief overview of the basic research on the treatment of laryngeal cancer with traditional Chinese medicine and extracts in recent years.
[1] Hinerman R, Mendenhall W, Amdur R, et al., 2002, Early Laryngeal Cancer. Curr Treat Options Oncol, 3(1): 3–9.
[2] Kim S, Han K, Joo Y, 2019, Metabolic Syndrome and Incidence of Laryngeal Cancer: A Nationwide Cohort Study. Sci Rep, 9(1): 667.
[3] Cox S, Daniel C, 2022, Racial and Ethnic Disparities in Laryngeal Cancer Care. J Racial Ethn Health Disparities, 9(3): 800–811.
[4] Silver J, Turkdogan S, Roy C, et al., 2023, Surgical Treatment of Early Glottic Cancer. Otolaryngol Clin North Am, 56(2): 259–273.
[5] Winkler C, 2015, Médecine Traditionnelle Chinoise et Rechutes de Cancers. Rev Infirm, 2015(207): 43.
[6] Wang J, Sun Y, Zhou X, et al., 2023, Mechanism of Baicalein-Mediated Autophagy Inhibiting Proliferation and Migration of Laryngeal Cancer Cells via the miR-449a/HDAC1 Axis. Chinese Journal of Comparative Medicine, 33(10): 45–53.
[7] Wang H, Xing R, Ma X, et al., 2023, Tanshinone IIA Promotes Apoptosis and Autophagy in Human Laryngeal Cancer Hep-2 Cells by Inhibiting the PI3K/Akt/mTOR Signaling Pathway. Modern Journal of Integrated Traditional Chinese and Western Medicine, 32(3): 308–314.
[8] Qiao B, Pang S, Wang H, 2023, Effects and Mechanism of Tanshinone IIA on Proliferation and Cell Cycle of Human Laryngeal Cancer Hep-2 Cells. Shaanxi Medical Journal, 52(8): 960–964.
[9] Zhang G, Xu Y, Zhou H, 2019, Esculetin Inhibits Proliferation, Invasion, and Migration of Laryngeal Cancer In Vitro and In Vivo by Inhibiting JAK/STAT3 Activation. Med Sci Monit, 25: 7853–7863.
[10] Dai L, Yu Q, Zhou S, et al., 2020, Combination of Curcumin and GLUT-1 AS-ODN Enhances Radiosensitivity of Laryngeal Carcinoma via Autophagy Regulation. Head Neck, 42(9): 2287–2297.
[11] Su Y, Luo Y, Zhang P, et al., 2023, Glucose-Induced CRL4COP1-p53 Axis Amplifies Glycometabolism to Drive Tumorigenesis. Mol Cell, 83(13): 2316–2331 + e7.
[12] Peng Y, Yang H, Li S, 2021, Role of Glycometabolic Plasticity in Cancer. Pathol Res Pract, 226: 153595.
[13] Tu A, Said N, Muddiman D, 2021, Spatially Resolved Metabolomic Characterization of Muscle-Invasive Bladder Cancer by Mass Spectrometry Imaging. Metabolomics, 17(8): 70.
[14] Wu X, Liu Y, Ao H, et al., 2022, Identification of Potential Biomarkers for Human Laryngeal Cancer Based on Dried Blood Spot Mass Spectrometry. Medicine (Baltimore), 101(8): e28820.
[15] Man S, Qiu P, Li J, et al., 2017, Global Metabolic Profiling of Rhizoma Paridis Saponins-Induced Hepatotoxicity in Rats. Environ Toxicol, 32(1): 99–108.
[16] Man S, Li J, Fan W, et al., 2015, Inhibition of Pulmonary Adenoma in Diethylnitrosamine-Induced Rats by Rhizoma Paridis Saponins. J Steroid Biochem Mol Biol, 154: 62–67.
[17] Qi W, Zhu F, Wang M, et al., 2022, Antitumoral Effect of Paris Saponin II on Head and Neck Squamous Cell Carcinoma via the Nitric Oxide Metabolic Pathway. Front Cell Dev Biol, 9: 803981.
[18] Liu W, Kang S, Chen H, et al., 2024, Ursolic Acid Derivatives Induce Apoptosis in Throat Cancer Cells via Akt/mTOR and Mitochondrial Pathways. J Ethnopharmacol, 319(Pt 3): 117351.
[19] Monzavi-Karbassi B, Kelly T, Post S, 2024, Tumor Microenvironment and Immune Response in Breast Cancer. Int J Mol Sci, 25(2): 914.
[20] Mhaidly R, Mechta-Grigoriou F, 2020, Fibroblast Heterogeneity in the Tumor Microenvironment: Role in Immunosuppression and Therapy. Semin Immunol, 48: 101417.
[21] Dong K, Huo M, Sun H, et al., 2020, Mechanism of Astragalus Membranaceus in Laryngeal Cancer Based on Gene Co-expression Network and Molecular Docking. Sci Rep, 10(1): 11184.
[22] Shi G, Zhao Y, Yan R, et al., 2023, Ginsenoside Rb2 Inhibits Proliferation and Migration of Laryngeal Cancer Cells via EMT Regulation. Chinese Journal of Laboratory Diagnosis, 27(1): 48–52.
[23] Khan Z, Nath N, Rauf A, et al., 2022, Multifunctional Roles and Pharmacological Potential of β-Sitosterol. Chem Biol Interact, 365: 110117.
[24] Wu Z, Zhu Z, Fu L, 2023, Network Pharmacology and In Vitro Analysis of Bruceae Fructus Against Laryngeal Cancer. Naunyn Schmiedebergs Arch Pharmacol, 397(6): 4165–4181.
[25] Chen X, Cubillos-Ruiz J, 2021, Endoplasmic Reticulum Stress Signals in Tumors and the Microenvironment. Nat Rev Cancer, 21(2): 71–88.
[26] Zhang Y, Liu H, Song Y, et al., 2021, Polysaccharide Extract of Hedyotis Diffusa Regulates Endoplasmic Reticulum Autophagy in Laryngeal Cancer Hep-2 Cells. Chinese Journal of Applied Physiology, 37(6): 660–664.
[27] Liu Z, Chen H, Zheng L, et al., 2023, Angiogenic Signaling Pathways and Anti-angiogenic Therapy in Cancer. Signal Transduct Target Ther, 8(1): 198.
[28] Patel S, Nilsson M, Le X, et al., 2023, Molecular Mechanisms and Therapeutic Implications of VEGF/VEGFR in Cancer. Clin Cancer Res, 29(1): 30–39.
[29] Li Z, Ge H, Xie Y, et al., 2023, Luteolin Inhibits Angiogenesis and Enhances Radiosensitivity of Laryngeal Cancer via Integrin β1 Downregulation. Tissue Cell, 85: 102235.
[30] Peng F, Du Q, Peng C, et al., 2015, Pharmacology of Isoliquiritigenin: A Review. Phytother Res, 29(7): 969–977.
[31] Yao J, Qian Z, Wei N, et al., 2023, Inhibitory Effect and Mechanism of Isoliquiritigenin on Laryngeal Cancer Growth In Vitro and In Vivo. Journal of Shanxi Medical University, 54(1): 60–68.
[32] Liu F, Niu Q, Wang A, et al., 2015, Effect of Isoliquiritigenin on the Invasive Ability of Gastric Cancer SGC7901 Cells. Tianjin Medical Journal, 43(11): 1267–1270.
[33] Hu A, Huang J, Jin X, et al., 2014, Curcumin Suppresses Invasiveness and Vasculogenic Mimicry of Laryngeal Squamous Cell Carcinoma via JAK2/STAT3 Inhibition. Am J Cancer Res, 5(1): 278–288.